Name | Org 25969 |
---|---|
Synonyms |
3,3',3'',3''',3'''',3''''',3'''''',3'''''''-{[(1S,3S,5S,6S,8S,10S,11S,13S,15S,16S,18S,20S,21S,23S,25S,26S,28S,30S,31S,33S,35S,36S,38S,40S,41R,42R,43R,44R,45R,46R,47R,48R,49R,50R,51R,52R,53R,54R,55R,56 ;R)-41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56-Hexadecahydroxy-2,4,7,9,12,14,17,19,22,24,27,29,32,34,37,39-hexadecaoxanonacyclo[36.2.2.2.2.2.2.2.2.2]h exapentacontane-5,10,15,20,25,30,35,40-octay
cyclooctakis-(1&;rarr;4)-[6-S-(2-carboxyethyl)-6-thio-α-D-glucopyranosyl] unii-361lpm2t56 Sugammadex UNII361LPM2T56 |
Description | Sugammadex is a synthetic γ-cyclodextrin derivative, and acts as a reversal agent for neuromuscular block. Sugammadex shows nephroprotective effect in ischemia-reperfusion injury[1][2]. |
---|---|
Related Catalog | |
In Vivo | Sugammadex (100 mg/kg, IV, once) has a nephroprotective effect when given at the beginning of reperfusion after one hour of ischemic condition on rats[2]. |
References |
Density | 1.6±0.1 g/cm3 |
---|---|
Molecular Formula | C72H104Na8O48S8 |
Molecular Weight | 2002.151 |
Exact Mass | 2000.408813 |
PSA | 994.80000 |
LogP | -1.25 |
Index of Refraction | 1.610 |